ErVimmune | $19,917,795 | (Jan 21, 2026)
Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
Certified by Founder
Lodge
NewLeaf Symbiotics, Inc.
start up
United States
- St. Louis, Missouri
- 21/12/2023
- Series D
- $45,000,000
NewLeaf Symbiotics is the industry’s undisputed Ag Biotech leader and pioneer of PPFM technology. The proud Champions of Pink Performance, NewLeaf works to harness pink-pigmented facultative methylotrophs – PPFMs – into actionable solutions to challenges around yield, crop protection, nutrient use efficiency and methane mitigation, with the intent of helping farmers do more with less as they work to feed a growing population.
- Industry Biotechnology Research
- Website https://www.newleafsym.com/
- LinkedIn https://www.linkedin.com/company/newleaf-symbiotics-inc-/
POINT.LAZ | $3,000,000 | (Jan 21, 2026)
Jetson(CANADA) | $50,000,000 | (Jan 21, 2026)
BrightInsight | $13,000,000 | (Jan 21, 2026)
Formulary Financial | $4,600,000 | (Jan 21, 2026)
Ultra Pouches | $11,000,000 | (Jan 21, 2026)
XBuild | $19,000,000 | (Jan 21, 2026)
Dam Secure | $4,000,000 | (Jan 21, 2026)
Infinitopes | $15,400,000 | (Jan 21, 2026)
Cosmos | $15,000,000 | (Jan 21, 2026)